Chemical Intermediates for US Pharma from Japan
Active pharmaceutical intermediates imported for final synthesis, crystallization, and formulation into US-manufactured prescription drugs.
Duty Rate — Japan → United States
12.5%
Rate breakdown
9903.05.4912.5%Except for products described in headings 9903.05.85–9903.05.92, articles the product of Japan, with an ad valorem (or ad valorem equivalent) rate of duty under column 1 less than 12.5 percent, as provided for in U.S. note 52 to this subchapter
Import Tips
• Include FDA-approved synthesis routes and batch records proving chemical transformation
• DEA controls apply to controlled substance intermediates regardless of processing
• Finished APIs classify under Chapter 29 or 30 pharmaceutical products